Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.28)
# 3,359
Out of 4,711 analysts
717
Total ratings
29.56%
Success rate
-10.01%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics | Reiterates: Buy | $5.75 | $2.53 | +127.27% | 17 | Dec 23, 2024 | |
| CYTK Cytokinetics | Reiterates: Buy | $120 | $49.08 | +144.52% | 40 | Dec 23, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $41.11 | +148.14% | 24 | Dec 20, 2024 | |
| CLDX Celldex Therapeutics | Reiterates: Buy | $80 | $24.69 | +224.08% | 29 | Dec 20, 2024 | |
| PTN Palatin Technologies | Reiterates: Buy | $17 | $1.00 | +1,600.17% | 25 | Dec 19, 2024 | |
| ARMP Armata Pharmaceuticals | Reiterates: Buy | $7 | $1.85 | +277.79% | 14 | Dec 19, 2024 | |
| KRYS Krystal Biotech | Reiterates: Buy | $221 | $161.57 | +36.79% | 25 | Dec 18, 2024 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $21 | $1.65 | +1,172.73% | 26 | Dec 18, 2024 | |
| BMEA Biomea Fusion | Reiterates: Buy | $40 | $4.14 | +867.35% | 23 | Dec 18, 2024 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $18 | $1.69 | +964.77% | 12 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.01 | +1,142.73% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.11 | +543.09% | 13 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $9.30 | +298.02% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.44 | +481.36% | 17 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $123 | $26.99 | +355.72% | 19 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.28 | +601.75% | 22 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $9.38 | - | 15 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.71 | +453.51% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $113.00 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.40 | +929.41% | 6 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $16.56 | +244.20% | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.23 | +753.24% | 14 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.75 | +1,235.47% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.30 | - | 7 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $0.55 | +1,541.74% | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $9 | $0.21 | +4,119.41% | 11 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $37 | $8.80 | +320.45% | 23 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.70 | +1,427.61% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.51 | +562.25% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.26 | +217.21% | 22 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.14 | - | 17 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $12.77 | +502.98% | 17 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.50 | +214.23% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $4.37 | +609.50% | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.83 | +464.43% | 9 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $0.77 | +6,030.97% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.66 | +808.40% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $13.91 | +130.05% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.14 | +320.56% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $7.46 | +329.17% | 26 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.02 | +397.91% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.65 | +2,953.90% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $4.54 | +362.38% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.27 | +2,916.59% | 8 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.17 | +1,052.74% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.64 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.62 | +1,875.31% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.90 | +934.48% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $9 | $12.28 | -26.71% | 2 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.91 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $32.08 | +2.88% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $4.15 | +1,779.52% | 1 | Mar 24, 2017 |
VYNE Therapeutics
Dec 23, 2024
Reiterates: Buy
Price Target: $5.75
Current: $2.53
Upside: +127.27%
Cytokinetics
Dec 23, 2024
Reiterates: Buy
Price Target: $120
Current: $49.08
Upside: +144.52%
Viking Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $102
Current: $41.11
Upside: +148.14%
Celldex Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $24.69
Upside: +224.08%
Palatin Technologies
Dec 19, 2024
Reiterates: Buy
Price Target: $17
Current: $1.00
Upside: +1,600.17%
Armata Pharmaceuticals
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $1.85
Upside: +277.79%
Krystal Biotech
Dec 18, 2024
Reiterates: Buy
Price Target: $221
Current: $161.57
Upside: +36.79%
PDS Biotechnology
Dec 18, 2024
Reiterates: Buy
Price Target: $21
Current: $1.65
Upside: +1,172.73%
Biomea Fusion
Dec 18, 2024
Reiterates: Buy
Price Target: $40
Current: $4.14
Upside: +867.35%
Tenaya Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $18
Current: $1.69
Upside: +964.77%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.01
Upside: +1,142.73%
Dec 17, 2024
Reiterates: Buy
Price Target: $20
Current: $3.11
Upside: +543.09%
Dec 17, 2024
Reiterates: Buy
Price Target: $37
Current: $9.30
Upside: +298.02%
Dec 16, 2024
Reiterates: Buy
Price Target: $20
Current: $3.44
Upside: +481.36%
Dec 13, 2024
Reiterates: Buy
Price Target: $123
Current: $26.99
Upside: +355.72%
Dec 13, 2024
Reiterates: Buy
Price Target: $16
Current: $2.28
Upside: +601.75%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $9.38
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.71
Upside: +453.51%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $113.00
Upside: -
Dec 10, 2024
Reiterates: Buy
Price Target: $35
Current: $3.40
Upside: +929.41%
Dec 10, 2024
Reiterates: Buy
Price Target: $57
Current: $16.56
Upside: +244.20%
Dec 10, 2024
Reiterates: Buy
Price Target: $2
Current: $0.23
Upside: +753.24%
Dec 9, 2024
Initiates: Buy
Price Target: $10
Current: $0.75
Upside: +1,235.47%
Dec 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.30
Upside: -
Dec 4, 2024
Maintains: Buy
Price Target: $7 → $9
Current: $0.55
Upside: +1,541.74%
Nov 25, 2024
Maintains: Buy
Price Target: $21 → $9
Current: $0.21
Upside: +4,119.41%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $37
Current: $8.80
Upside: +320.45%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.70
Upside: +1,427.61%
Nov 15, 2024
Reiterates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $1.26
Upside: +217.21%
Nov 15, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $77
Current: $12.77
Upside: +502.98%
Nov 14, 2024
Reiterates: Buy
Price Target: $11
Current: $3.50
Upside: +214.23%
Nov 14, 2024
Reiterates: Buy
Price Target: $31
Current: $4.37
Upside: +609.50%
Nov 14, 2024
Reiterates: Buy
Price Target: $16
Current: $2.83
Upside: +464.43%
Nov 13, 2024
Reiterates: Buy
Price Target: $47
Current: $0.77
Upside: +6,030.97%
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $0.66
Upside: +808.40%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $13.91
Upside: +130.05%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $2.14
Upside: +320.56%
Nov 6, 2024
Reiterates: Buy
Price Target: $32
Current: $7.46
Upside: +329.17%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $5.02
Upside: +397.91%
Aug 16, 2024
Reiterates: Buy
Price Target: $20
Current: $0.65
Upside: +2,953.90%
Aug 6, 2024
Reiterates: Buy
Price Target: $21
Current: $4.54
Upside: +362.38%
Aug 1, 2024
Reiterates: Buy
Price Target: $8
Current: $0.27
Upside: +2,916.59%
May 16, 2024
Reiterates: Buy
Price Target: $2
Current: $0.17
Upside: +1,052.74%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.64
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.62
Upside: +1,875.31%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.90
Upside: +934.48%
Mar 11, 2020
Reiterates: Buy
Price Target: $11 → $9
Current: $12.28
Upside: -26.71%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.91
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $32.08
Upside: +2.88%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $4.15
Upside: +1,779.52%